https://www.selleckchem.com/products/smifh2.html
001). The odds ratio (OR) of miR-101a in univariate analysis was 0.41 (95% CI, 0.33-0.52). After adjusting for the traditional risk factors, such as blood profiles and history of smoking, the odds ratio of miR-101a was 0.63 (95% CI, 0.47-0.43), which closely associated with CHD (p = 0.002). Circulating miR-101a may be considered as a novel biomarker for evaluating the presence and severity of CHD. Circulating miR-101a may be considered as a novel biomarker for evaluating the presence and severity of CHD.It is estimated that more than 20%
Like
Comment
Share
